< Back to Article
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients
Table 9
Biomarker models, LASSO selection.
Benign tumors vs. borderline + cancer.
doi: https://doi.org/10.1371/journal.pone.0240418.t009